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Summary
To quantify the effect of the apolipoprotein (apo) E polymorphism on the magnitude of postprandial lipemia,
we have defined its role in determining the response to a single high-fat meal in a large sample of (N = 474)
individuals taking part in the biethnic Atherosclerosis Risk in Communities Study. The profile of postprandial
response in plasma was monitored over 8 h by triglyceride, triglyceride-rich lipoprotein (TGRL)-triglyceride,
apo B-48/apo B-100 ratio, and retinyl palmitate concentrations, and the apo E polymorphism was determined
by DNA amplification and digestion. The frequency of the apo E alleles and their effects on fasting lipid levels
in this sample were similar to those reported elsewhere. Postprandial plasma retinyl palmitate response to a
high-fat meal with vitamin A was significantly different among apo E genotypes, with delayed clearance in
individuals with an £2 allele, compared with £3/3 and £3/4 individuals. In the sample of 397 Caucasians,
average retinyl palmitate response was 1,489 ttg/dl in £2/3 individuals, compared with 1,037 jig/dl in £3/3
individuals and 1,108 Ftg/dl in £3/4 individuals. The apo E polymorphism accounted for 7.1% of the
interindividual variation in postprandial retinyl palmitate response, a contribution proportionally greater than
its well-known effect on fasting LDL-cholesterol. However, despite this effect on postprandial retinyl palmitate,
the profile of postprandial triglyceride response was not significantly different among apo E genotypes. The
profile of postprandial response was consistent between the sample of Caucasians and a smaller sample of black
subjects. While these data indicate that the removal of remnant particles from circulation is delayed in subjects
with the £2/3 genotype, there is no reported evidence that the £2 allele predisposes to coronary artery disease
(CAD). The results of this study provide not only a reliable estimate of the magnitude of the effect of the apo
E polymorphism on various measurements commonly used to characterize postprandial lipemia, but also provide
mechanistic insight into the effects of the apo E gene polymorphism on postprandial lipemia and CAD.
Introduction
The role of plasma triglycerides in the pathogenesis of
coronary artery disease (CAD) is controversial. Numer-
ous epidemiological studies have found that fasting
plasma triglyceride concentrations are associated with
CAD (Austin 1991). However, on multivariate analyses
including the effects of other lipids, especially HDL-
cholesterol, the association between triglycerides and
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CAD is not maintained. Even though HDL-cholesterol
may be a better predictor of CAD, animal experiments
and studies of the postprandial state in man provide
evidence that the concentration of HDL-cholesterol is
largely dependent on the metabolism of triglyceride-
rich lipoproteins (Patsch et al. 1984; Miesenbock and
Patsch 1990). It has been argued that prolonged post-
prandial lipemia is conducive to the development of
atherosclerosis (Zilversmit 1979), and case-control stud-
ies have shown that late postprandial lipid levels are
predictive of CAD, even when HDL-lipoproteins are
simultaneously considered (Groot et al. 1991; Patsch et
al. 1992a; Ryu et al. 1992).
While the magnitude and duration of postprandial
lipemia is relatively constant within an individual given
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uniform meal challenges, there are considerable differ-
ences in postprandial response among individuals
(Patsch et al. 1984, 1987; Brown et al. 1992). A number
of factors have been identified that influence postpran-
dial response, including age (Krasinski et al. 1990), sex
(Cohn et al. 1988b), the concentration of fasting triglyc-
erides (Nestel 1964; Cohn et al. 1988a; Brown and Rob-
erts 1991), and alcohol consumption (Wilson et al.
1970). The extent of postprandial lipemia is also in-
fluenced by genetic factors. Patients with genetically
determined CETP deficiency (Inazu et al. 1990), type III
hyperlipidemia (Weintraub et al. 1987), and lipoprotein
lipase deficiency (Brunzell 1989; Miesenbock et al.
1993) all have exaggerated postprandial lipid responses.
However, the rare frequency of these genetic condi-
tions dictates that the underlying mutations are not re-
sponsible for a large fraction of the variability in post-
prandial response in the general population.
Because of its recognized importance in remnant
clearance, the apolipoprotein (apo) E gene has been tar-
geted for the study of postprandial lipid response
(Mahley and Rall 1989). Apo E plays a major role in
lipid metabolism through cellular uptake of lipoprotein
particles by apo E-specific and apo B/E receptors on
the liver and other tissues (Mahley et al. 1990). E2-con-
taining lipoproteins have lower affinity for hepatic lipo-
protein receptors, compared with lipoproteins contain-
ing E3 (Hui et al. 1984; Schneider et al. 1981;
Weisgraber et al. 1982). In addition, the conversion of
VLDL to LDL in the plasma of patients with familial
type III hyperlipoproteinemia is impeded by the apo E2
isoform but can be restored by addition of apo E3
(Ehnholm et al. 1984), suggesting a role of apo E in the
conversion of VLDL to LDL. Consistent with the func-
tion of the apo E2 isoform, several studies have shown a
reduction in the clearance of postprandial lipoproteins
in subjects carrying an s2 allele (Gregg et al. 1986; Bren-
ninkmeijer et al. 1987; Weintraub et al. 1987; Brown
and Roberts 1991; Superko and Haskell 1991). In vitro,
the receptor-binding affinity of E4-containing lipopro-
teins may be similar to those containing the common
E3 isoform, but, in vivo, apo E4-containing lipopro-
teins are cleared more rapidly from circulation than are
those containing apo E3. Dallongeville et al. (1992) and
Brown and Roberts (1991) have reported that the apo E
polymorphism influences fasting plasma triglyceride lev-
els. Compared with individuals with the s3/3 genotype,
s3/4 subjects had higher fasting triglyceride levels,
which, in turn, are related to the magnitude and dura-
tion of postprandial lipemia (Cohn et al. 1988a; Brown
and Roberts 1991). Results from studies on the role of
the £4 allele in postprandial lipid metabolism are incon-
sistent, showing either decreased (Brenninkmeijer et al.
1987; Weintraub et al. 1987) or increased (Brown and
Roberts 1991) postprandial response.
On the basis of results of several epidemiologic stud-
ies, an association between apo E genotypes and preva-
lent CAD has been established (Menzel et al. 1983;
Cumming and Roberts 1984; Lenzen et al. 1986). The
frequency of the £2 allele is reduced among CAD pa-
tients, while the frequency of the &4 allele is increased.
Results from these studies are commonly attributed to
differences in LDL-cholesterol levels, qualifying an ap-
parent importance of remnants and postprandial lipe-
mia in atherogenesis. To quantitatively estimate the
contribution of the apo E polymorphism to distinct
metabolic aspects of postprandial lipoprotein metabo-
lism, we have measured multiple parameters of post-
prandial response in a biracial sample of 474 individuals
taking part in the Atherosclerosis Risk in Communities
(ARIC) Study. We report here that the £2 allele in-
creased late postprandial retinyl palmitate concentra-
tions in subjects consuming a high-fat test meal con-
taining vitamin A but had no effect on late postprandial
triglycerides. The s4 allele had no significant effect on
any of the postprandial variables measured, even after
correction for fasting triglycerides. Furthermore, the
effect of the apo E polymorphism on postprandial re-
tinyl palmitate levels was larger than the well-estab-
lished effect of this system on LDL-cholesterol. Hence,
these data indicate that the effects of the common apo
E polymorphism on remnant and LDL metabolism do
not fully explain the observed association of this gene
with CAD.
Methods
Sampling and Postprandial Protocol
Participants were selected from the ARIC study, a
prospective, multicenter investigation of atherosclero-
sis and its sequelae in women and men 45-64 years of
age. Approximately 16,000 residents were recruited
into the ARIC study, 4,000 in each of four communi-
ties: Forsyth County, NC; the city of Jackson, MS; the
northwestern suburbs of Minneapolis; and Washington
County, MD. Each sample was a probability sample
designed to be representative of residents living in that
community, except for the Jackson sample, which con-
sisted only of black residents. The general design of the
ARIC study is described elsewhere (ARIC Investigators
1989). Participants were selected from the total ARIC
population on the basis of the average thickness of the
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carotid arteries as determined by B-mode ultrasound
(Bond et al. 1991). Subjects were designated cases if the
maximum carotid arterial wall thickness was greater
than 2.5 mm or if there was bilateral thickening above
approximately the 90th percentile of the ARIC study
cohort. Controls were defined by a carotid artery far-
wall thickness of less than the 75th percentile. Cases
and controls were group matched for race, gender, 10-
year age group, field center, and date of examination.
Therefore, the conclusions presented here are not di-
rectly extendable to the general population. Analyses
characterizing the relationship between the extent and
duration of postprandial lipemia and case status are the
subject of future publications. In this paper, we focus
on the role of the apo E polymorphism in determining
the postprandial profile in this sample of ARIC partici-
pants. Analyses were carried out to test whether the
effect of the apo E polymorphism on postprandial re-
sponse was not significantly different between cases
and controls; it was not (results not shown). Exclusion
criteria for participation in the postprandial study were
(1) evidence of symptomatic cardiovascular or cerebro-
vascular disease defined by history of angina on effort;
(2) physician-diagnosed heart attack, transient ischemic
attack, stroke, or intermittent claudication; (3) use of
lipid-altering medication such as beta blockers, thia-
zides, hypolipidemics, or thyroid medication; (4) use of
sex hormones, including oral contraceptives in pre-
menopausal women; (5) diabetes mellitus; (6) renal dis-
ease; (7) liver disease; (8) hypertriglyceridemia defined
as a fasting triglyceride level >400 mg/dl; (9) nonstan-
dard diets, such as a vegetarian diet; (10) lactose intoler-
ance; or (11) history of pancreatitis.
Data were collected from a total of 474 individuals
consisting of 397 Caucasians and 77 blacks, 295 males
and 179 females. For technical reasons, the number of
observations for triglyceride-rich lipoproteins (TGRL),
the apo B-48/apo B-100 ratio in TGRL, and retinyl
palmitate in blacks was less than the total number of
black participants. The average (±SD) age and body-
mass index of the Caucasians were 55.9 (±5.2) years
and 26.4 (±4.1) kg/M2, respectively. In blacks these
values were 55.8 (±5.9) years and 27.9 (±5.4) kg/M2,
respectively. The influence of the apo E polymorphism
on the magnitude and duration of the postprandial re-
sponse was not significantly different between males
and females (P = .67 for retinyl palmitate and P = .87
for triglycerides). Therefore, in this paper, results are
presented for the combined sample of males and fe-
males.
On the day of the fat-tolerance test, study partici-
pants arrived at the field centers after fasting for 12 h,
and a blood specimen was taken before administration
of the test meal. For each two square meters of body
surface area as determined from weight and height mea-
surements (Lohman et al. 1988), a liquid meal was in-
gested containing 1,237 kcal, 32.7 g of protein, 47.8 g
of carbohydrate, 300 mg of cholesterol, 105 g of fat,
and 100,000 IU of vitamin A (Aquasol; Armour Phar-
maceutical, Kankakee, IL). The polyunsaturated-fat/
saturated-fat ratio was 0.369, and the polyunsaturated-
fat/monounsaturated-fat ratio was 0.754. Participants
were instructed not to take anything by mouth except
water, sugarless drinks, or coffee, for a period of 8 h
after ingestion of the test meal. Postprandial blood spec-
imens were collected into EDTA-containing tubes (1.5
mg/ml of blood) at 3.5 and 8 h. Plasma was separated
by centrifugation (1,500 g for 20 min at 4°C) and was
stored in the dark at 4°C for 1-3 d. All plasma speci-
mens were shipped on crushed ice to the Central Lipid
Laboratory at Baylor College of Medicine, Houston.
Lipid measurements were performed within 7 d after
arrival, with the exception of retinyl palmitate, which
was analyzed in batches from plasma stored under ni-
trogen in light-protected ampules.
Laboratory Measures
Cholesterol and triglyceride concentrations were
measured enzymatically on a Cobas-Fara centrifugal
analyzer (Roche Diagnostics, Montclair, NJ) with the
respective enzymatic kits (catalog nos. 236691 and
701912; Boehringer-Mannheim Diagnostics, Indiana-
polis). HDL-cholesterol was determined by measuring
cholesterol in the supernatant after precipitation with
MgCl2 and dextran sulfate (Warnick et al. 1982; Patsch
et al. 1989). Plasma apo B and A-I levels were measured
by radioimmunoassay according to the methods of
Schonfeld et al. (1974) and Brown et al. (1988), respec-
tively.
TGRL were isolated from 5 ml of plasma from the 0-,
3.5-, and 8-h blood specimens by ultracentrifugation
(Lipid Research Clinics Program 1982). Samples were
spun for 18 h at 10°C at 105,000 g in a Beckman 50.3
rotor. The top fraction was obtained by tube slicing,
and triglycerides were determined by enzymatic meth-
ods as described above. Cholesterol and apo B were
measured in the infranate. LDL-cholesterol was calcu-
lated by subtraction of total HDL-cholesterol. To de-
termine the apo B-48/apo B-100 ratio in TGRL, ali-
quots of the top fraction were precipitated with 10%
trichloroacetic acid and 0.03% desoxycholate. Precipi-
tates were dissolved in sample buffer containing
343
Boerwinkle et al.
0.025% bromophenol blue and were subjected to SDS
gel electrophoresis in a Bio-Rad Mini-Protean II cell
(Bio-Rad Laboratories, Hercules, CA) using a 3% stack-
ing gel and a 5% separating gel according to the method
of Laemmli (1970). Electrophoresis was performed for
90 min at 100 V. Gels were stained with 0.25% Coo-
massie blue G-250 for 1 h and destained in 40% metha-
nol and 10% acetic acid (v%) for 20 h. Relative abun-
dance of apo B-48 and apo B-100 (the apo B-48/apo
B-100 ratio) was determined by scanning of the de-
stained gels by using a laser densitometer equipped with
an automated integration module (LKB Ultrascan XL;
Pharmacia LKB Biotechnology, Piscataway, NJ).
Retinyl palmitate levels in plasma were determined
by high-pressure liquid chromatography (HPLC)
(Waters 501 HPLC pump, Waters 486 tunable absor-
bance detector, Waters 712 sample processor, and
Waters 743 data module; Waters Instruments, Milford,
MA). The assay was carried out in subdued light with
HPLC-grade solvents. Retinol from 0.5 ml of plasma
denatured with an equal volume of absolute ethanol
was extracted by the addition of 7.5 ml of hexane. Six
and one half milliliters of the hexane phase were re-
moved and evaporated to dryness under a gentle stream
of N2 at room temperature. The resulting residues were
dissolved in 200 jl of methanol/chloroform (4/1 [v/
v]) and were passed through a 0.45-,um HV filter (Milli-
pore, Milford, MA), and 50-jl aliquots were injected
into a 3.9 x 150-mm Nova-Pack C 18 4-jim HPLC
column (Waters, Milford, MA). Acetonitrile/metha-
nol/methylene chloride (70/15/15 [v/v/v]) was used
as the mobile phase at a flow rate of 1.8 ml/min (Ama-
dee-Manesme et al. 1984). The effluent was monitored
at 325 nm, and the peak of retinyl palmitate was identi-
fied by comparison with the retention time of a purified
standard (Sigma Chemical, St. Louis). The amount of
retinyl palmitate in plasma was quantified by regression
analysis using integrated areas of unknowns and stan-
dard dilutions. The correlation between concentration
and integrated areas in five dilutions of standard un-
knowns was typically >.98.
Apo E genotypes were determined by restriction iso-
typing (Hixson and Vernier 1990). Genomic DNA was
extracted from frozen buffy coats, amplified by the
PCR (Saiki et al. 1988) using the primers reported by
Emi et al. (1988), and was restricted with HhaI. The
apo E genotypes were typed directly from the ethidium
bromide-stained 12% polyacrylamide gels.
Statistical Analyses
Allele frequencies were estimated by the method of
gene counting. Agreement with Hardy-Weinberg equi-
librium expectations was tested using a %2 goodness-of-
fit test. Differences in allele frequencies among Cauca-
sians and blacks were tested using a 2 X 3 contingency
X2 (Snedecor and Cochran 1980).
Prior to analysis of the effects of the apo E gene on
fasting lipid, lipoprotein, apo, and retinyl palmitate lev-
els, these measures were adjusted, by multiple linear
regression (Neter et al. 1990), for the concomitant ef-
fects of sex, age, body-mass index, disease status, ciga-
rette smoking, and alcohol consumption. Retinyl pal-
mitate was also adjusted for the influence of fasting
triglyceride levels. Both the analysis of variance (Neter
et al. 1990) and a more robust nonparametric test, the
Kruskal-Wallis test (Conover 1980; Daniel 1990), were
used to investigate the effects of the apo E gene on the
adjusted fasting measures of lipid metabolism. Normal-
izing transformations such as logarithms and square
root were avoided because they lack intuitive appeal
and result in loss of the original scale.
The effect of the apo E polymorphism on the post-
prandial profile of lipid, lipoprotein, apo, and retinyl
palmitate levels was investigated using either a re-
peated-measures analysis-of-variance model (Neter et
al. 1990) or profile analysis (Morrison 1976). Specifi-
cally, the hypothesis of primary interest was the F-test
of interaction between the apo E polymorphism and
time, which tests whether the response to the high fat
load was the same among apo E types. Postprandial
"response" was defined as the difference between lev-
els 8 h postprandially and fasting, a measure that was
found to be a highly informative predictor of CAD in a
cross-sectional study (Patsch et al. 1992a). The effect of
the apo E polymorphism on this measure of response
was tested using the analysis-of-variance (Neter et al.
1990) and the Kruskal-Wallis nonparametric test (Con-
over 1980; Daniel 1990). The proportion of interindi-
vidual variation, in this response, attributable to the
apo E polymorphism was calculated using the R2 from
the analysis of variance.
Results
The observed frequencies of each of the apo E geno-
types are shown, for Caucasians and blacks, respec-
tively, in the first row of table 1 and the first row of
table 2. As expected on the basis of the results of numer-
ous other studies (Hallman et al. 1991; Gerdes et al.
1992), the most common group in both races was the
£3/3 genotype, followed by the £3/4 and £2/3 geno-
types. In the sample of Caucasians there were only two
£2/2 individuals. In the sample of blacks no individuals
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Table I
Fasting Plasma Lipid, Lipoprotein, and Apo Levels in the Sample of Caucasians
MEAN (SD)
VARIABLE £2/2 £2/3 e2/4 e3/3 £3/4 £4/4 Overall P pb
No. of subjects ....... 2 44 10 260 73 8 397
Total
cholesterol ......... 194.3 (40.6) 196.3 (39.9) 187.9 (36.6) 202.9 (34.9) 207.1 (31.4) 196.5 (22.4) 202.4 (34.7) .35 (.28) .27 (.15)
LDL-cholesterol ....... 118.9 (33.8) 117.7 (31.7) 115.6 (26.3) 136.2 (34.1) 136.6 (28.5) 128.0 (26.7) 133.5 (33.0) .01 (.01) .005 (.003)
Apo B ................ 101.4 (38.8) 93.5 (27.8) 99.6 (34.4) 103.3 (31.9) 102.5 (26.0) 101.2 (29.0) 101.9 (30.5) .60 (.48) .17 (.11)
Apo B
in LDL ............. 80.7 (22.8) 74.4 (18.2) 86.0 (30.3) 85.2 (29.3) 92.2 (26.2) 91.2 (25.7) 85.5 (27.9) .07 (.04) .008 (.004)
Apo B-48/
apo B-100 .......... .059 .034 (.023) .028 (.027) .031 (.021) .033 (.020) .046 (.037) .032 (.022) .32 (.47) .75 (.72)
Triglycerides .......... 165.7 (58.0) 135.8 (75.4) 122.7 (75.4) 122.6 (57.8) 141.9 (111.6) 119.7 (42.2) 127.8 (72.9) .40 (.70) .11 (.63)
Triglycerides
in VLDL ........... 107.2 (70.2) 75.5 (54.5) 74.5 (66.8) 77.4 (60.7) 97.4 (113.1) 69.4 (30.2) 80.8 (72.5) .45 (.89) .13 (.81)
HDL-cholesterol ...... 41.7 (6.52) 44.3 (14.5) 49.2 (10.9) 43.9 (11.9) 44.4 (8.60) 46.7 (13.3) 44.2 (11.6) .78 (.51) .94 (.51)
Apo Al ............... 132.8 (38.7) 125.0 (27.2) 127.2 (21.2) 120.0 (26.6) 124.6 (21.3) 134.4 (23.4) 121.9 (25.7) .37 (.43) .28 (.34)
a Probability that average levels are not significantly different among the six apo E genotypes. The value given in parentheses is this probability based on a
nonparametric Kruskal-Wallis test (see Methods).
b Probability that average levels are not significantly different among the three common apo E genotypes (£2/3, £3/3, and £3/4). The value given in parentheses is
this probability based on a nonparametric Kruskal-Wallis test (see Methods).
were observed with the £2/2 or £4/4 genotype, and
only one person was observed with the £2/4 genotype.
Because the depth of inference based on these rare
classes is limited, the analyses presented below were
carried out for all apo E genotypes and then were re-
peated considering only the three common genotypes
-s2/3s, s3/3s, and s3/4s. The estimated frequencies
of the £2, £3, and £4 alleles in the sample of Caucasians
Table 2
Fasting Plasma Lipid, Lipoprotein, and Apo Levels in the Sample of Blacks
MEAN (SD)
VARIABLE £2/3 e2/4 £3/3 £3/4 Overall pa pb
No. of subjects ....... 13 1 47 16 77
Total
cholesterol .......... 196.8 (50.0) 170.6 215.4 (33.1) 198.0 (42.5) 208.0 (38.9) .19 (.10) .15 (.09)
LDL-cholesterol ....... 109.7 (51.8) 119.5 136.5 (32.2) 130.0 (38.0) 130.9 (36.5) .44 (.73) .27 (.58)
Apo B ............... 91.7 (36.7) 80.9 97.8 (21.8) 115.8 (38.6) 100.5 (29.5) .19 (.50) .12 (.40)
Apo B
in LDL ............. 109.7 (51.8) 119.5 136.5 (32.2) 130.0 (38.0) 130.9 (36.5) .44 (.65) .91 (.91)
Apo B-48/
apo B-100 .......... .037 (.029) .054 .037 (.030) .029 (.018) .035 (.027) .78 (.62) .73 (.88)
Triglycerides .......... 124.6 (56.5) 83.6 96.8 (40.0) 108.7 (57.0) 103.8 (47.2) .28 (.36) .16 (.23)
Triglycerides
in VLDL ........... 88.3 (64.4) 58.4 54.3 (33.2) 71.5 (65.5) 63.3 (47.8) .35 (.45) .20 (.27)
HDL-cholesterol ...... 44.4 (13.0) 37.1 54.9 (16.9) 45.6 (16.6) 51.0 (16.7) .08 (.04) .05 (.03)
Apo Al ............... 124.0 (18.5) 131.6 134.5 (31.5) 132.9 (43.9) 132.5 (33.1) .89 (.64) .74 (.47)
a Probability that average levels are not significantly different among the four apo E genotypes. The value given in parentheses is this
probability based on a nonparametric Kruskal-Wallis test (see Methods).
b Probability that average levels are not significantly different among the three common apo E genotypes (&2/3, E3/3, and s3/4). The value
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Figure I Profile of postprandial triglyceride (A), TGRL-triglyceride (B), apo B-48/apo B-100 ratio (C), and retinyl palmitate (D) levels,
for each of the common apo E genotypes in 397 Caucasian subjects from the ARIC study. E-H, Profile of postprandial triglyceride, TGRL-
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were .073, .802, and .125, respectively. In the sample of
blacks, these values were .091, .799, and .110, respec-
tively. The estimated allele frequencies were not signifi-
cantly different between Caucasians and blacks (X2
= 0.76, P = .68). In addition, the observed genotype
frequencies shown in tables 1 and 2 are in agreement
with Hardy-Weinberg expectations, in both racial
groups.
The effect of the apo E polymorphism on fasting
plasma lipid, lipoprotein, and apo levels is shown in
tables 1 and 2, for Caucasians and for blacks, respec-
tively. When the test of interaction from a two-way
analysis of variance was used, the effects of the apo E
polymorphism on these measures were not significantly
different between Caucasians and blacks. In Cauca-
sians, average LDL-cholesterol and LDL-apo B levels
were consistently different among apo E genotypes.
Both LDL-cholesterol and LDL-apo B levels were signif-
icantly lower in individuals with at least one £2 allele,
compared with those with the common £3/3 genotype.
LDL-apo B levels were higher, and LDL-cholesterol lev-
els were only slightly higher, in individuals with the
£3/4 genotype, compared with those with the common
£3/3 genotype. Of particular relevance to the analysis
of postprandial response presented below, individuals
with the £3/4 genotype had higher, but not signifi-
cantly higher, plasma triglyceride and TGRL-triglycer-
ide levels than did individuals with either of the other
two common apo E genotypes. As in the sample of
Caucasians, average LDL-cholesterol and LDL-apo B
levels were lower in black individuals with an £2 allele,
but these effects did not reach statistical significance. In
this sample of black subjects, HDL-cholesterol levels
were also different among apo E types. Average HDL-
cholesterol levels were higher in s3/3 individuals, com-
pared with individuals with either of the other two
common apo E types.
The profile of postprandial triglyceride, TGRL-tri-
glyceride, apo B-48/apo B-100 ratio, and retinyl palmi-
tate response for each of the common apo E genotypes
is shown in figure lA-1D, respectively, for the sample
of Caucasians. These data are plotted in figure 1E-lH,
for the sample of blacks. The characteristic profiles for
postprandial triglycerides and TGRL-triglycerides are
significantly different from random in both racial
groups (P < .0001). However, the profile of postpran-
dial triglyceride and TGRL-triglyceride change was not
different among the common apo E genotypes. In Cau-
casians, postprandial triglyceride concentrations in-
creased from 128.6 (±75.2) mg/dl at fasting to 270.8
(±130.5) mg/dl at 3.5 h, followed by a decrease to
193.7 (±137.1) mg/dl at 8 h. Average TGRL-triglycer-
ide concentrations were 81.2 (±72.8) mg/dl at fasting,
194.9 (±114.0) mg/dl at 3.5 h, and 126.9 (±116.9) mg/
dl at 8 h.
The apo B-48/apo B-100 ratio determined here is a
measure of the relative contribution of intestinally de-
rived apo B-48-based lipoproteins, such as chylomi-
crons and chylomicron remnants, to apo B-100-con-
taining lipoproteins primarily VLDL, from the liver.
The pattern of postprandial response for the apo B-48/
apo B-100 ratio (fig. 1C) is similar to those observed for
triglycerides (fig. 1A) and TGRL-triglycerides (fig. 1B).
This pattern was also not significantly different among
apo E genotypes. In Caucasians, the mean value of the
apo B-48/apo B-100 ratio increased from .032 (±.022)
at fasting to .063 (±.033) at 3.5 h, followed by a de-
crease to .043 (±.028) at 8 h. In this sample of blacks,
average apo B-48/apo B-100 ratios were .036 (±.027) at
fasting, .068 (±.062) at 3.5 h, and .042 (±.028) at 8 h.
In Caucasians, the profile of postprandial retinyl pal-
mitate was significantly different among apo E geno-
types (F = 4.08; 4 and 654 df; P = .003); however, the
profile of response was very similar between fasting and
3.5 h but diverged between 3.5 h and 8 h. Late post-
prandial retinyl palmitate levels were significantly
higher in individuals with the s2/3 genotype, compared
with individuals with either of the other apo E geno-
types. For example, average late postprandial retinyl
palmitate levels were 1,462.9 (±736.9) jig/dl in s2/3
individuals, compared with 1,072.0 (±604.2) jtg/dl in
the £3/3 individuals. The influence of the apo E poly-
morphism on the postprandial retinyl palmitate profile
in blacks was similar to that observed in Caucasians,
but it did not reach statistical significance. As in Cauca-
sians, black s2/3 individuals showed a larger postpran-
dial increase, compared with individuals with either of
the other apo E genotypes. In both Caucasians and
blacks, the postprandial profile of individuals with the
£3/4 genotype was not significantly different from the
profile in individuals with the £3/3 genotype.
The distribution of postprandial response in Cauca-
sians, as measured by the difference in plasma triglycer-
ide, TGRL-triglyceride, apo B-48/apo B-100 ratio, and
retinyl palmitate concentrations between 8 h and base-
line, is shown in figure 2, in panels A-D, respectively. In
a previous study (Patsch et al. 1992a) this measure of
postprandial triglyceride response was shown to be
highly predictive of CAD. The average and median re-
sponses for triglycerides were 66.1 and 56.9 mg/dl, re-
spectively. As a measure of general spread of the data,
the SD of triglyceride response was 72.7 mg/dl, and the
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Table 3
Average Postprandial Response of Plasma Triglyceride and Retinyl Palmitate Levels in Caucasians
MEAN (SD)
VARIABLE e2/2 £2/3 £2/4 £3/3 £3/4 £4/4 Overall pa pb
No. of subjects ...... 2 44 10 260 73 8 397
Triglycerides ......... 92.0 (10.1) 73.6 (73.3) 89.1 (58.8) 66.0 (74.1) 62.1 (71.9) 28.9 (46.2) 66.1 (72.7) .55 (.25) .72 (.65)
Triglycerides
in VLDL .......... 43.8 44.0 (65.8) 66.8 (31.4) 43.8 (73.8) 52.6 (67.1) 6.7 (75.5) 45.4 (71.0) .60 (.32) .69 (.54)
Apo B-48/
apo B-100 ......... .0023 .0083 (.023) .027 (.023) .012 (.028) .0072 (.019) .011 (.016) .011 (.026) .38 (.27) .44 (.34)
Retinyl
palmitate .......... 2,064 (34) 1,489 (701) 1,598 (499) 1,037 (595) 1,108 (75) 1,283 (869) 1,124 (661) .0001 (.0001) .0004 (.0005)
aProbability that average levels are not significantly different among the six apo E genotypes. The value given in parentheses is this probability based on a
nonparametric Kruskal-Wallis test (see Methods).
" Probability that average levels are not significantly different among the three common apo E genotypes (£2/3, £3/3, and s3/4). The value given in parentheses is
this probability based on a nonparametric Kruskal-Wallis test (see Methods).
distribution was positively skewed (y, = .886). Most
individuals showed a moderate increase in triglycerides;
half the individuals in this sample had a response be-
tween 22.0 and 94.7 mg/dl. However, some individuals
had a very high response (10% were >153 mg/dl), and
some individuals even had a negative response when
measured by this simple difference. For TGRL-triglycer-
ides, the average and median responses were 45.4 and
32.1 mg/dl, respectively, with an SD of 71.0 mg/dl. For
the apo B-48/apo B-100 ratio, the average and median
responses were .011 and .0088, respectively, with an SD
of .026. For retinyl palmitate, the average and median
responses were 1,123.8 and 1,012.8 gg/dl, respectively,
with an SD of 660.8 gg/dl. The 25th and 75th percen-
tiles of retinyl palmitate response were 662.0 and
1,416.7 ,g/dl, respectively. However, there is a sub-
stantial group of people (10%) with a postprandial
retinyl palmitate response of >2,000 ,ug/dl.
The effect of the apo E polymorphism on the post-
prandial response of triglycerides, TGRL-triglycerides,
apo B-48/apo B-100 ratio, and retinyl palmitate are
presented in tables 3 and 4. In Caucasians (table 3),
average triglyceride response is not significantly differ-
ent among apo E genotypes. When only the common
apo E genotypes are considered, average triglyceride
response was somewhat higher in £2/3 individuals and
lower in s3/4 individuals, compared with that in c3/3
individuals. In blacks (table 4), average triglyceride re-
sponse was higher in £3/4 individuals, compared with
individuals with either of the other two common apo E
types-an effect opposite to that observed in Cauca-
sians. However, these differences did not reach statisti-
cal significance in either race. As was seen for total
triglycerides, average TGRL-triglycerides were not sig-
nificantly different among apo E genotypes in either
Caucasians or blacks, and no clear pattern emerged for
the effect of the apo E polymorphism on this trait.
Therefore, we conclude that there is no significant evi-
dence that the common apo E polymorphism affects
postprandial total triglyceride or TGRL-triglyceride re-
sponse in this sample. Similarly, the data shown in ta-
bles 3 and 4 suggest that there is no significant effect of
the apo E polymorphism on the apo B-48/apo B-100
ratio.
In contrast to triglycerides and the apo B-48/apo
B-100 ratio, the postprandial response of retinyl palmi-
tate was significantly different among apo E genotypes.
In Caucasians, average retinyl palmitate response was
1,489.4 jg/dl in £2/3 individuals, compared with
1,036.7 gg/dl in £3/3 individuals. Even though the
number of £2/2 individuals is small, their average post-
prandial response is even higher than that of the £2/3
individuals, potentially indicating an additive effect of
the £2 allele on postprandial response. Postprandial re-
sponse of retinyl palmitate concentrations was very sim-
ilar between £,3/3 and £3/4 subjects. In blacks, the
direction and magnitude of the effect of the apo E poly-
morphism on retinyl palmitate response was the same
as that observed in Caucasians, but it did not reach
statistical significance. Average retinyl palmitate re-
sponse was 1,619.7 gg/dl in £2/3 individuals, com-
pared with 1,284.3 gg/dl in £3/3 individuals. When a
two-way analysis of variance (Neter et al. 1990) was
used on the pooled sample of Caucasians and blacks,
the effect of the apo E polymorphism on postprandial




Average Postprandial Response of Plasma Triglyceride and Retinyl Palmitate Levels in Blacks
MEAN (SD)
VARIABLE £2/3 £2/4 e3/3 £3/4 Overall pa pb
No. of subjects ...... 13 1 47 16 77
Triglycerides ......... 92.1 (88.9) -13.0 96.2 (95.0) 151.5 (186.7) 105.1 (118.6) .30 (.26) .26 (.43)
Triglycerides
in VLDL .......... 95.3 (72.6) .76 79.1 (114.3) 119.5 (98.5) 89.3 (103.8) .62 (.17) .59 (.23)
Apo B-48/
apo B-100 ......... .012 (.016) .0027 .0021 (.035) .016 (.018) .0075 (.029) .53 (.38) .34 (.23)
Retinyl
palmitate .......... 1,619.7 (786.3) 459.7 1,284.3 (590.9) 1,356.3 (661.8) 1,334.5 (642.3) .34 (.33) .47 (.54)
a Probability that average levels are not significantly different among the four apo E genotypes. The value given in parentheses is this
probability based on a nonparametric Kruskal-Wallis test (see Methods).
b Probability that average levels are not significantly different among the three common apo E genotypes (£2/3, £3/3, and £3/4). The value
given in parentheses is this probability based on a nonparametric Kruskal-Wallis test (see Methods).
but the interaction between the apo E polymorphism
and race was not significant (P = .92). We conclude
from these data that this gene polymorphism does have
a significant influence on the postprandial retinyl pal-
mitate response, but this effect is not different between
Caucasians and blacks.
We next calculated the contribution of differences in
apo E genotypes to the interindividual variation in
postprandial response. In both Caucasians and blacks,
7.13% of the interindividual variation in postprandial
retinyl palmitate response was attributable to the apo E
polymorphism. As expected, the contribution of the
apo E polymorphism to the other three response vari-
ables was less than that for retinyl palmitate. Among
both Caucasians and blacks, the contribution of the
apo E polymorphism to the interindividual variation in
response was <2% for total triglycerides, TGRL-triglyc-
erides, and the apo B-48/apo B-100 ratio. For compara-
tive purposes, 4.1% of the variance in fasting LDL-cho-
lesterol concentrations in this sample of Caucasians
was attributable to the apo E polymorphism; this value
is similar to that reported elsewhere (Boerwinkle and
Utermann 1988) in other populations. Therefore, the
proportional contribution of apo E to the interindivid-
ual variance in postprandial response as measured by
retinyl palmitate is greater than that for fasting LDL-
cholesterol.
Discussion
Interindividual variability in postprandial lipid trans-
port after a standard meal exceeds that observed in the
fasting state (Patsch et al. 1984, 1987; Brown et al.
1992) and is influenced by numerous environmental
and genetic factors affecting the synthesis and catabo-
lism of TGRL originating from the liver and intestine.
To quantify the effect of the apo E polymorphism on
the magnitude of the postprandial lipemia, we have in-
vestigated its effect on postprandial triglyceride,
TGRL-triglyceride, apo B-48/apo B-100 ratio, and
retinyl palmitate profiles in a large sample from the
ARIC study. The frequency of the apo E alleles and the
effects of the apo E polymorphism on fasting lipid lev-
els in this sample were similar to those reported in other
studies (Hallman et al. 1991; Gerdes et al. 1992). The
profiles of postprandial triglyceride, TGRL-triglycer-
ide, and apo B-48/apo B-100 ratio were not signifi-
cantly different among apo E genotypes. Average levels
of each of these three variables increased during the
first 3.5 h postprandially but decreased between 3.5
and 8 h. Average retinyl palmitate levels increased
throughout the 8-h time period. The postprandial pro-
file and response of plasma retinyl palmitate levels were
significantly different among apo E genotypes. Individ-
uals with an s2 allele had significantly higher postpran-
dial retinyl palmitate response, compared with £3/3
and £3/4 subjects. The apo E polymorphism accounted
for 7.1% of the interindividual variation in 8-h post-
prandial retinyl palmitate response, a value greater than
that observed for fasting LDL-cholesterol.
Because of the large sample size and outpatient de-
sign of this study, only two postprandial blood speci-
mens were collected, at 3.5 and 8 h. The rationale for
selecting these two time points was to obtain basic in-
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formation about the shape of the postprandial curve for
select analytes and to include a late postprandial sam-
ple, shown previously to discriminate patients with an-
giographically verified CAD from control subjects
without CAD (Patsch et al. 1992a). The analyses in-
cluded total plasma triglycerides as well as triglycerides
from the d < 1.006-g/ml fraction, as measures of gen-
eral postprandial lipemia. They also included retinyl
palmitate concentrations in plasma, as a measure more
specific to intestinally derived lipoproteins (Hazzard
and Bierman 1976; Berr and Kern 1984). Indeed, post-
prandial retinyl palmitate concentrations are thought
to provide a better measure of chylomicron remnant
clearance than do postprandial triglyceride concentra-
tions (Brenninkmeijer et al. 1987; Weintraub et al.
1987). To obtain an additional estimate of the contri-
bution of intestinally derived lipoproteins, the apo
B-48/apo B-100 ratio in d < 1.006-g/ml lipoproteins
was determined. The validity of this ratio is, however,
not absolute, since the intestine may also synthesize
and secrete a variable fraction of apo B-100 (Hoeg et al.
1990).
Numerous reports have indicated that the apo E poly-
morphism influences plasma lipid levels. Hallman et al.
(1991) have studied the frequency and effects of the
apo E polymorphisms among nine ethnically and geo-
graphically diverse populations. They concluded that,
although the frequencies of the apo E alleles are hetero-
geneous among populations, the effects of this gene are
relatively consistent: the average effect of the £2 allele is
to lower plasma cholesterol levels, and the average ef-
fect of the £4 allele is to raise plasma cholesterol levels.
Similar results have been obtained in studies of U.S.
blacks (Eichner et al. 1989). Even though the relative
frequency of the 64 allele is higher in blacks compared
with Caucasians, the same effects of the apo E poly-
morphism on plasma cholesterol levels are apparent
(Eichner et al. 1989). These alterations in total choles-
terol levels are primarily due to the effects of this gene
on LDL-cholesterol specifically (Boerwinkle and Uter-
mann 1988). The apo E polymorphism may also influ-
ence plasma triglyceride concentrations (Dallongeville
et al. 1992). In particular, individuals with the £3/4
genotype are usually reported to have elevated triglycer-
ides, compared with £3/3 subjects. In our sample, aver-
age fasting and postprandial triglyceride concentrations
in both Caucasians and blacks tended to be higher in
both the 62/3s and the 63/4s, compared with those in
individuals with the common £3/3 genotype, though
this relationship was not statistically significant or con-
sistent. In our sample of blacks, marginally significant
differences in HDL-cholesterol among apo E types
were observed, with the 63/3s having higher HDL-cho-
lesterol, compared with the 62/3s and 63/4s. It is inter-
esting that Srinivasan et al. (1989) also reported that
serum apo E concentrations, which are greatly affected
by the apo E polymorphism (Boerwinkle and Utermann
1988), are related to HDL-cholesterol levels in blacks.
The exact mechanism of these observations is un-
known but may result from the ability of the apo E
isoforms to complex with apo All (Innerarity et al.
1978). Alternatively, it may reflect differences in plasma
triglycerides among apo E genotypes (Dallongeville et
al. 1992) and the inverse relationship between triglycer-
ides and HDL-cholesterol (Patsch et al. 1992b).
The apo E isoforms differ by two cysteine to arginine
substitutions, at positions 112 and 158 in the apo E
protein (Weisgraber et al. 1981). Substitution of an argi-
nine by a cysteine at position 158 reduces the receptor-
binding affinity of the E2 isoform (Weisgraber et al.
1982; Hui et al. 1984). Reduced binding affinity of the
E2 isoform for hepatic lipoprotein receptors and subse-
quent up-regulation of LDL-receptor density have been
proposed as the most likely mechanism for the effect of
this gene on plasma LDL-cholesterol and total choles-
terol concentrations (Weintraub et al. 1987; Boerwin-
kle and Utermann 1988). It is also the likely mechanism
for the increased late postprandial retinyl palmitate
concentrations in 62/3 subjects observed in the present
study.
Previous studies on apo E and postprandial lipemia
have considered much smaller samples than are avail-
able in the ARIC study (Gregg et al. 1986; Brennink-
meijer et al. 1987; Weintraub et al. 1987; Brown and
Roberts 1991; Superko and Haskell 1991). In their semi-
nal paper, Weintraub et al. (1987) first reported that
clearance of dietary fats were different among apo E
types, with 62 individuals having delayed clearance and
with 64 individuals having faster clearance, as ascer-
tained by both retinyl palmitate concentrations in
plasma and the nonchylomicron fraction. The effect of
the 64 allele was consistent with in vivo studies showing
that radioactively labeled apo E4 is cleared faster than
apo E3 (Gregg et al. 1986). A more rapid transfer of apo
E4 to chylomicron remnants was thought to account
for its faster clearance. While these studies have pro-
vided mechanistic insights, they may not be representa-
tive of the effect of the 64 allele on postprandial lipemia
in the population at large.
The mechanism whereby the 64 allele increases fast-
ing plasma triglycerides is not known. It is conceivable
that enhanced uptake of intestinal TGRL that results
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from a more rapid association of apo E4 with chylomi-
crons (Innerarity et al. 1978; Gregg et al. 1986; Wein-
traub et al. 1987) influences plasma triglycerides. In
hepatocyte preparations, uptake of chylomicron rem-
nants is associated with increased VLDL production
(Craig et al. 1988). Increased association of intestinal
TGRL with apo E4 may render these particles amena-
ble for endocytosis at an earlier stage of delipidation,
thereby increasing hepatic fatty-acid concentrations,
which is known to drive hepatic VLDL-triglyceride se-
cretion. The fact that the s4 allele is associated with
hypercholesterolemia (Utermann et al. 1984) as well as
with type V hyperlipemia (Ghiselli et al. 1982) is consis-
tent with the notion that a common mechanism (i.e.,
uptake of triglyceride-rich remnants) may underlie
these observations. Dependent on other genetic and
environmental factors regulating VLDL synthesis and
catabolism, including its conversion to LDL, two dif-
ferent phenotypes may be expressed in £4-carrying sub-
jects. Association of the e4 allele with hypertriglyceri-
demia in obesity (Fumeron et al. 1988; Gueguen et al.
1989) suggests that the &4 allele is conducive to en-
hanced hepatic lipoprotein production that is charac-
teristic of obesity in general (Kesaniemi and Grundy
1983; National Institute of Health Consensus Develop-
ment Panel on the Health Implications of Obesity
1985). Hence, impaired metabolism of TGRL may con-
tribute to the association of the s4 allele with CAD, but
the relative importance of increased LDL-cholesterol as
opposed to increased triglyceride levels awaits further
study.
Our data confirm the results of others showing in-
creased retinyl palmitate response in c2/3 subjects. Un-
like retinyl palmitate concentrations, postprandial tri-
glyceride levels did not differ among apo E genotypes.
The size of our sample provides confidence in the disso-
ciation of postprandial triglyceride and retinyl palmi-
tate levels, which is consistent with defective clearance
of fully delipidated particles. Defective clearance of in-
testinal lipoproteins would be expected to increase the
relative proportion of apo B-48 in the d < 1.006-g/ml
lipoprotein fraction. However, retinyl palmitate levels
in £2/3 subjects exceeded those in £3/3 subjects by
<50%. Since apo B-48 contributed only 4% of the total
apo B in the TGRL fraction of £3/3 subjects at the 8-h
time point and since quantification of apo B subspecies
is associated with a larger methodological error than
are other measurements, apo E-specific differences in
the relative proportion of apo B subspecies may have
remained undetected had they occurred. Alternatively,
a very small amount of retinyl palmitate could have
been transferred among lipoprotein particles (Berr
1992), slightly overestimating the contribution of intes-
tinal lipoproteins to the remnant pool in plasma.
Using labeled cholesterol and betasitosterol feeding,
Kesaniemi et al. (1987) showed that the £2 allele is asso-
ciated with lower intestinal cholesterol absorption than
are the £3 and s4 alleles. However, as reported here,
£2-containing individuals show increased postprandial
response as measured by retinyl palmitate. Should such
apo E-specific differences in absorption also apply to
retinol, this result would still be valid; but it may have
actually underestimated the effect of the s2 allele on
remnant clearance.
At least five lines of evidence implicate postprandial
lipoprotein metabolism in the genesis of CAD. First,
receptor-mediated uptake of triglyceride-rich remnant
particles by monocyte-derived macrophages promotes
the formation of lipid-laden foam cells in the vessel wall
(Brown and Goldstein 1983; Gianturco et al. 1988;
Huff et al. 1991). Similarly, uptake of isolated chylomi-
cron remnants by cultured human arterial smooth-
muscle cells results in the accumulation of intracellular
cholesterol (Floren et al. 1981). Second, chylomicron
and VLDL remnants make a substantial contribution to
the lipid content of the vessel wall in cholesterol-fed
rabbits (Stender and Zilversmit 1982; Daugherty et al.
1985). Third, the level of HDL-cholesterol, an estab-
lished risk factor for CAD, is dependent on both the
metabolism of TGRL particles and the extent of post-
prandial lipemia (Nikkila et al. 1987; Patsch et al. 1987;
Tall 1990). This metabolic interrelationship is mediated
largely by the action of cholesteryl ester transfer pro-
tein (Albers et al. 1984; Tall 1986). Fourth, patients
with familial dysbetalipoproteinemia are at high risk of
CAD and show a buildup of TGRL remnants of both
intestinal and hepatic origin (Fainaru et al. 1982). These
remnant particles have a propensity for uptake by mac-
rophages, which are subsequently transformed into
foam cells (Mahley and Rall 1989). A similar type of
hyperlipidemia can be induced in various animal species
by an atherogenic diet, and the severity of atherosclero-
sis induced correlates with the remnant concentration
attained in circulation (Stender and Zilversmit 1982;
Daugherty et al. 1985). Fifth, Groot et al. (1991) and
Patsch et al. (1992a) found in cross-sectional case-con-
trol studies that increased postprandial triglycerides,
alone or in combination with increased retinyl palmi-
tate concentrations, are associated with angiographi-
cally verified CAD. In addition, Ryu et al. (1992) re-
ported an association between the magnitude of
postprandial response and carotid artery wall thickness.
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While the data of the present study and of other
studies indicate that the terminal step of the remnant
pathway, i.e., their removal from circulation, is delayed
in subjects with the s2/3 genotype, there is no evidence
that the £2 allele predisposes to CAD. In contrast, a
moderately protective role of this allele has been sug-
gested in some studies (Hixson et al. 1991). Thus, other
factors, such as enhanced VLDL production by the
liver or impaired lipolysis of TGRL, irrespective of their
origin, must be implicated in the atherogenesis of rem-
nant particles. Such a hypothesis is in keeping with both
the pathophysiology of type III hyperlipoproteinemia
(Mahley and Rall 1989) and recent studies showing that
increased postprandial triglyceride levels are predictive
of CAD (Groot et al. 1991; Patsch et al. 1992a; Ryu et
al. 1992). In both diseases, impaired metabolism of
TGRL results in rerouting of cholesteryl esters from
HDL into TGRL. The amount of cholesteryl esters en-
tering the remnant pathway in these diseases is greatly
increased, and it is conceivable that their atherogenic
potential is enhanced. The atherogenic potential of
these cholesteryl ester-enriched remnants is further en-
hanced in type III hyperlipoproteinemia, because of
their prolonged residence time in circulation, which, in
turn, is due to the receptor-binding deficiency of the
apo E2 isoform (Mahley and Rall 1989). In contrast, the
£2 allele alone is associated with increased postprandial
retinyl palmitate, but not with triglyceride levels. In
fact, the £2 allele, because of its defective interaction
with hepatic receptors (Hui et al. 1984; Schneider et al.
1981; and Weisgraber et al. 1982), may be associated
with reduced hepatic triglyceride production, for rea-
sons described above. Thus, our studies not only pro-
vide a reliable estimate of the magnitude of the effect of
the apo E polymorphism on various measurements
commonly used to characterize postprandial lipemia,
but also provide mechanistic insight into the effects of
the apo E gene polymorphism on postprandial lipemia
and CAD.
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